GOLDMAN SACHS GROUP INC - CALUMET SPECIALTY PRODS PTNR ownership

CALUMET SPECIALTY PRODS PTNR's ticker is CLMT and the CUSIP is 131476103. A total of 51 filers reported holding CALUMET SPECIALTY PRODS PTNR in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CALUMET SPECIALTY PRODS PTNR
ValueSharesWeighting
Q3 2023$10,811,670
+23.4%
566,056
+2.4%
0.00%0.0%
Q2 2023$8,764,093
-9.8%
552,591
-1.1%
0.00%0.0%
Q1 2023$9,712,604
+10.3%
558,838
+7.1%
0.00%0.0%
Q4 2022$8,808,001
+186.4%
521,801
+117.4%
0.00%
+100.0%
Q3 2022$3,075,000
-6.0%
240,041
-23.8%
0.00%0.0%
Q2 2022$3,273,000
-21.3%
315,032
+3.0%
0.00%0.0%
Q1 2022$4,161,000
-13.1%
305,765
-15.7%
0.00%0.0%
Q4 2021$4,790,000
-13.9%
362,900
-48.4%
0.00%0.0%
Q3 2021$5,564,000
-13.8%
703,449
-25.1%
0.00%0.0%
Q2 2021$6,452,000
+115.2%
939,162
+91.1%
0.00%0.0%
Q1 2021$2,998,000
+196.2%
491,501
+52.0%
0.00%
Q4 2020$1,012,000
+22.7%
323,3630.0%0.00%
Q3 2020$825,000
+9.0%
323,363
-2.6%
0.00%
Q2 2020$757,000
+116.9%
331,9240.0%0.00%
Q1 2020$349,000
-71.2%
331,9240.0%0.00%
Q4 2019$1,212,000
+0.3%
331,9240.0%0.00%
Q3 2019$1,208,000
-21.1%
331,924
-9.2%
0.00%
Q2 2019$1,532,000
-19.3%
365,531
-31.5%
0.00%
-100.0%
Q1 2019$1,899,000
+91.0%
533,451
+18.6%
0.00%
Q4 2018$994,000
-85.1%
449,687
-57.0%
0.00%
-100.0%
Q3 2018$6,692,000
-6.2%
1,045,625
+9.2%
0.00%0.0%
Q2 2018$7,134,000
+8.6%
957,626
+2.7%
0.00%0.0%
Q1 2018$6,571,000
+34.3%
932,015
+46.7%
0.00%
+100.0%
Q4 2017$4,893,000
-27.4%
635,536
-21.3%
0.00%0.0%
Q3 2017$6,742,000
+171.4%
807,461
+38.2%
0.00%0.0%
Q2 2017$2,484,000
-28.2%
584,428
-35.8%
0.00%0.0%
Q1 2017$3,458,000
-6.2%
910,027
-1.2%
0.00%0.0%
Q4 2016$3,686,000
+114.1%
921,459
+141.5%
0.00%
Q3 2016$1,722,000
+84.4%
381,622
+100.2%
0.00%
Q2 2016$934,000
-64.4%
190,645
-14.7%
0.00%
-100.0%
Q1 2016$2,626,000
-43.1%
223,446
-3.7%
0.00%0.0%
Q4 2015$4,619,000
+67.8%
231,982
+104.6%
0.00%0.0%
Q3 2015$2,752,000
-31.5%
113,388
-28.1%
0.00%0.0%
Q2 2015$4,015,000
-22.1%
157,712
-26.4%
0.00%
-50.0%
Q1 2015$5,156,000
+131.3%
214,404
+115.6%
0.00%
+100.0%
Q4 2014$2,229,000
-12.9%
99,467
+6.7%
0.00%0.0%
Q3 2014$2,558,000
+20.6%
93,181
+39.7%
0.00%0.0%
Q2 2014$2,121,000
+40.0%
66,722
+13.9%
0.00%
Q1 2014$1,515,000
+22.7%
58,601
+23.4%
0.00%
Q4 2013$1,235,000
-37.6%
47,488
-34.4%
0.00%
-100.0%
Q3 2013$1,978,000
+28.5%
72,429
+71.2%
0.00%
Q2 2013$1,539,000
+22.0%
42,298
+1.9%
0.00%
Q4 2012$1,261,000
-21.0%
41,496
-16.8%
0.00%
Q3 2012$1,596,000
-3.5%
49,881
-28.3%
0.00%
Q2 2012$1,654,000
+74.5%
69,550
+93.7%
0.00%
Q1 2012$948,00035,9100.00%
Other shareholders
CALUMET SPECIALTY PRODS PTNR shareholders Q3 2020
NameSharesValueWeighting ↓
Evermore Global Advisors, LLC 2,249,209$7,040,0007.61%
Adams Asset Advisors, LLC 4,555,224$14,257,0003.90%
KNOTT DAVID M 2,645,000$8,279,0003.75%
Springhouse Capital Management, LP 356,722$1,117,0001.08%
Barnett & Company, Inc. 309,882$969,0000.61%
Windsor Wealth Management, Inc. 206,176$645,0000.16%
Danda Trouve Investment Management, Inc. 17,738$56,0000.07%
O'Brien Greene & Co. Inc 33,001$103,0000.04%
Plancorp, LLC 45,000$141,0000.04%
Accel Wealth Management 10,306$32,0000.03%
View complete list of CALUMET SPECIALTY PRODS PTNR shareholders